Whole-genome sequencing is now easily done for very little cost. It is not known how to interpret the results of this testing. It is inadvisable for healthy individuals to undergo routine whole-genome sequencing but if someone has a reason to suspect a particular disease known to be associated with a unique gene, then targeted genetic sequencing is reasonable.
Interviewee: James P. Evans, MD, PhD, from the University of North Carolina at Chapel Hill.
Fler avsnitt av JAMA Clinical Reviews
Visa alla avsnitt av JAMA Clinical ReviewsJAMA Clinical Reviews med JAMA Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
